Immune-mediated inflammatory disease may increase risk of severe COVID-19 outcomes

By | September 14, 2021
Researchers in the UK have conducted a large population-based study showing that people with immune-mediated inflammatory diseases (IMIDs) appear to be at an increased risk of serious outcomes from coronavirus disease 2019 (COVID-19).